11.   The panel is still discussing conditions that would have to accompany any recommendation for approval of a thalidomide drug, which could include marketing restrictions or limited physician access.

12.   Warren New Jersey-based Celgene developed its thalidomide drug for use in a skin condition called erythema nodosum leprosum, or ENL.